CAS RN: 1131594-69-8
Ethyl 3-broMo-4-(4-Methylpiperazin-1-yl)benzoate
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g
- Available purity: ≥95%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1131594-69-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
-- |
1
In Stock
|
Shanghai |
Inquiry |
| 0.1g |
≥95% |
1
In Stock
|
Beijing |
Inquiry |
| 0.25g |
-- |
1
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
≥95% |
1
In Stock
|
Shanghai |
Inquiry |
| 1g |
-- |
1
In Stock
|
Shanghai |
Inquiry |
| 1g |
≥95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 5g |
-- |
0
Out of Stock
|
Shanghai |
Inquiry |
| 5g |
≥95% |
0
Out of Stock
|
Hong Kong |
Inquiry |
1131594-69-8 / ethyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate
ethyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate | Ethyl 3-Bromo-4-(4-methyl-1-piperazinyl)benzoate | MFCD11110937
Standard CAS: 1131594-69-8
Multi CAS: No
Basic Information
CAS
1131594-69-8
Multi CAS
No
Molecular Formula
C14H19BrN2O2
Molecular Weight
327.220000
Exact Mass
326.062990
SMILES
CCOC(=O)C1=CC(=C(C=C1)N2CCN(CC2)C)Br
InChI
InChI=1S/C14H19BrN2O2/c1-3-19-14(18)11-4-5-13(12(15)10-11)17-8-6-16(2)7-9-17/h4-5,10H,3,6-9H2,1-2H3
InChIKey
PHLZSBLTLYGWOM-UHFFFAOYSA-N
Synonyms
ethyl 3-bromo-4-(4-methylpiperazin-1-yl)benzoate
Ethyl 3-Bromo-4-(4-methyl-1-piperazinyl)benzoate
MFCD11110937
SCHEMBL31593035
DTXSID80662428
Computed Properties
Structural Parameters
Heavy atom count
19
Aromatic heavy atom count
6
Fraction Csp3
0.5
Rotatable bonds
3
H-bond acceptors
4
Molar refractivity
79.81
TPSA
32.78
LogP / Solubility
WLOGP
2.38
MLOGP
2.11
XLogP3
2.8
Consensus LogP
2.43
Log S (ESOL)
-3.4
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.96
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.12
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.03
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
1.5